Published in Proc Natl Acad Sci U S A on January 09, 1996
Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci U S A (1997) 7.90
Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol Cell Biol (2001) 1.55
Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis. Arthritis Rheum (2008) 1.05
Glucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophages. Br J Pharmacol (2001) 0.99
Inhaled fluticasone propionate impairs pulmonary clearance of Klebsiella pneumoniae in mice. Respir Res (2012) 0.98
Corticotropin-releasing hormone deficiency unmasks the proinflammatory effect of epinephrine. Proc Natl Acad Sci U S A (1999) 0.90
PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages. Br J Pharmacol (2007) 0.87
Paradoxical early glucocorticoid induction of stem cell factor (SCF) expression in inflammatory conditions. Br J Pharmacol (2003) 0.85
Regulation of induction of nitric oxide synthase and the inhibitory actions of dexamethasone in the human intestinal epithelial cell line, Caco-2: influence of cell differentiation. Br J Pharmacol (1999) 0.83
Differential modulatory effects of annexin 1 on nitric oxide synthase induction by lipopolysaccharide in macrophages. Immunology (2006) 0.81
Nitric oxide modulators: an emerging class of medicinal agents. Indian J Pharm Sci (2012) 0.78
Signalling mechanisms involved in the induction of inducible nitric oxide synthase by Lactobacillus rhamnosus GG, endotoxin, and lipoteichoic acid. Inflammation (2002) 0.78
Lymphadenectomy promotes tumor growth and cancer cell dissemination in the spontaneous RET mouse model of human uveal melanoma. Oncotarget (2015) 0.76
Inhibition by tetranactin of interleukin 1 beta- and cyclic AMP-induced nitric oxide synthase expression in rat renal mesangial cells. Br J Pharmacol (1996) 0.75
Intratympanic dexamethasone on cochlear blood flow in Guinea pigs. Indian J Otolaryngol Head Neck Surg (2012) 0.75
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res (1983) 124.30
Gene regulation by steroid hormones. Cell (1989) 12.96
Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science (1986) 9.19
Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell (1990) 6.56
Nitric oxide synthases in mammals. Biochem J (1994) 6.50
Regulation of biosynthesis of nitric oxide. J Biol Chem (1994) 4.82
Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A (1990) 4.49
Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J Exp Med (1993) 3.06
Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci (1993) 2.86
Nitric oxide: mediator, murderer, and medicine. Lancet (1994) 2.74
Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem Biophys Res Commun (1990) 2.31
Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem (1994) 2.02
Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms. J Clin Invest (1988) 1.93
Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J Biol Chem (1994) 1.49
Transforming growth factor beta 2 inhibits interleukin 1 beta- and tumour necrosis factor alpha-induction of nitric oxide synthase in rat renal mesangial cells. Biochem Biophys Res Commun (1991) 1.39
Two distinct signaling pathways trigger the expression of inducible nitric oxide synthase in rat renal mesangial cells. Proc Natl Acad Sci U S A (1994) 1.33
Interleukin 1 beta and tumour necrosis factor alpha induce a macrophage-type of nitric oxide synthase in rat renal mesangial cells. Eur J Biochem (1992) 1.20
Interleukin 1 and tumor necrosis factor stimulate cGMP formation in rat renal mesangial cells. FEBS Lett (1990) 1.20
Cross-talk between transmembrane signalling systems: a prerequisite for the delicate regulation of glomerular haemodynamics by mesangial cells. Eur J Clin Invest (1989) 1.18
Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. Biochem Biophys Res Commun (1994) 1.17
Transforming growth factor-beta 1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleukin-1 beta in rat smooth muscle cells. J Biol Chem (1994) 1.14
Nitric oxide: an inflammatory mediator of glomerular mesangial cells. Nephron (1993) 1.03
Regulation of inducible nitric oxide synthase gene by interleukin-1 beta in rat vascular endothelial cells. Am J Physiol (1994) 1.02
Pyrrolidine dithiocarbamate differentially affects interleukin 1 beta- and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells. Biochem Biophys Res Commun (1994) 0.97
Expression of nitric oxide synthase in rat glomerular mesangial cells mediated by cyclic AMP. Br J Pharmacol (1994) 0.95
Cyclosporin derivatives inhibit interleukin 1 beta induction of nitric oxide synthase in renal mesangial cells. Eur J Pharmacol (1993) 0.92
Anti-inflammatory steroids inhibit cytokine induction of nitric oxide synthase in rat renal mesangial cells. Eur J Pharmacol (1991) 0.90
Nicotinamide and dexamethasone inhibit interleukin-1-induced nitric oxide production by RINm5F cells without decreasing messenger ribonucleic acid expression for nitric oxide synthase. Endocrinology (1993) 0.86
Dexamethasone differentially affects interleukin 1 beta- and cyclic AMP-induced nitric oxide synthase mRNA expression in renal mesangial cells. Biochem J (1994) 0.86
Estimating the cots required for neonatal intensive care. Arch Dis Child (1981) 2.73
Femtosecond modification of electron localization and transfer of angular momentum in nickel. Nat Mater (2007) 2.57
Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J (2001) 2.52
Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol (2000) 2.42
Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones. Proc Natl Acad Sci U S A (1987) 2.29
Islet-cell antibodies in diabetes mellitus. Lancet (1976) 2.20
Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes. EMBO J (2001) 2.06
Incidence of familial melanoma and MLM2 gene. Lancet (1994) 2.03
Apaf-1 oligomerizes into biologically active approximately 700-kDa and inactive approximately 1.4-MDa apoptosome complexes. J Biol Chem (2000) 1.94
Prevalence and risk factors for meticillin-resistant Staphylococcus aureus in adult emergency admissions--a case for screening all patients? J Hosp Infect (2007) 1.89
When do pregnant women attend for antenatal care? Br Med J (1980) 1.88
The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int (2009) 1.85
Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim Biophys Acta (2000) 1.77
Hepatic disorders associated with liver-kidney microsomal antibodies. Br Med J (1974) 1.64
Mitochondrial antibodies (AMA). Gut (1974) 1.60
Measurement of glycosylated hemoglobin on cellulose acetate membranes by mobile affinity electrophoresis. Clin Chem (1983) 1.58
Counterregulation of interleukin-18 mRNA and protein expression during cutaneous wound repair in mice. J Invest Dermatol (1999) 1.58
The morbidity of long-term seizure monitoring using subdural strip electrodes. J Neurosurg (1991) 1.53
Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (augmentin) Dig Dis Sci (1989) 1.52
Lensless imaging of magnetic nanostructures by X-ray spectro-holography. Nature (2004) 1.50
Vascular access for hemodialysis in children. Pediatr Nephrol (1997) 1.48
Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium. J Exp Med (1990) 1.48
Immunopathology of liver disease. Prog Liver Dis (1972) 1.47
Who cares for Missouri's Medicaid nursing home residents? Characteristics of attending physicians. J Am Geriatr Soc (1993) 1.47
Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease. Gut (1974) 1.47
Ferromagnetism in one-dimensional monatomic metal chains. Nature (2002) 1.46
Laminin and basement membrane-associated microfilaments in wild-type and mutant Drosophila ovarian follicles. J Cell Sci (1991) 1.45
Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair. J Clin Invest (2000) 1.45
Effects of transforming growth factor-beta on osteoblastic osteosarcoma cells. Endocrinology (1987) 1.42
Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab (2001) 1.42
[The prevention of osteoporosis]. Dtsch Med Wochenschr (2001) 1.39
Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Lancet (1975) 1.38
Acid resistance of enamel subsurface lesions remineralized by a sugar-free chewing gum containing casein phosphopeptide-amorphous calcium phosphate. Caries Res (2004) 1.38
ON THE LACK OF EVIDENCE OF TRANSMISSION BY HUMAN BEINGS OF TUBERCULOSIS DUE TO THE BOVINE TYPE OF BACILLUS. Br Med J (1934) 1.38
Large tunable Rashba spin splitting of a two-dimensional electron gas in Bi2Se3. Phys Rev Lett (2011) 1.37
The dynamics of interorganizational coordination. Adm Sci Q (1984) 1.35
Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase. Proc Natl Acad Sci U S A (1996) 1.34
Two distinct signaling pathways trigger the expression of inducible nitric oxide synthase in rat renal mesangial cells. Proc Natl Acad Sci U S A (1994) 1.33
Plasma prednisolone levels and adrenocortical responsiveness after administration of prednisolone-21-phosphate as a retention enema. Gut (1979) 1.32
Hypoxia induces macrophage inflammatory protein-2 (MIP-2) gene expression in murine macrophages via NF-kappaB: the prominent role of p42/ p44 and PI3 kinase pathways. FASEB J (2004) 1.31
Two energy gaps and Fermi-surface "arcs" in NbSe2. Phys Rev Lett (2009) 1.30
The function of nitric oxide in wound repair: inhibition of inducible nitric oxide-synthase severely impairs wound reepithelialization. J Invest Dermatol (1999) 1.29
Distributed situation awareness in dynamic systems: theoretical development and application of an ergonomics methodology. Ergonomics (2006) 1.29
Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process. Proc Natl Acad Sci U S A (1986) 1.25
Failure of potassium siphoning by Müller cells: a new hypothesis of perfluorocarbon liquid-induced retinopathy. Invest Ophthalmol Vis Sci (2000) 1.22
Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proc Natl Acad Sci U S A (1988) 1.20
Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects. J Clin Oncol (1999) 1.20
Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW). Osteoporos Int (2010) 1.19
Expression and release of IL-18 binding protein in response to IFN-gamma. J Immunol (2001) 1.19
Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair. FASEB J (1999) 1.16
I. Sarcoma of the Kidney in Children: A Critical Review of the Pathology, Symptomatology, Prognosis, and Operative Treatment as seen in One Hundred and Forty-five Cases. Ann Surg (1897) 1.16
Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1beta and cAMP in rat mesangial cells. J Immunol (1998) 1.14
Pertussis toxin abolishes angiotensin II-induced phosphoinositide hydrolysis and prostaglandin synthesis in rat renal mesangial cells. Biochem J (1986) 1.14
[Prevention, diagnosis, therapy, and follow-up of lung cancer]. Pneumologie (2010) 1.14
Role of phospholipase C and protein kinase C in vasoconstrictor-induced prostaglandin synthesis in cultured rat renal mesangial cells. Biochem J (1986) 1.13
Rectally administered prednisolone--evidence for a predominantly local action. Gut (1980) 1.12
Activation of phospholipase C and prostaglandin synthesis by [arginine]vasopressin in cultures. Biochem J (1984) 1.12
Ultrastructural changes in the small intestine induced by ethanol. Gastroenterology (1972) 1.12
The fine structure of the frontal filament complex of barnacle larvae (Crustacea: cirripedia). Cell Tissue Res (1974) 1.11
Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest (2001) 1.11
Femtosecond electron and spin dynamics in Ni/W(110) films. Phys Rev Lett (2003) 1.11
Stimulation by extracellular ATP and UTP of the mitogen-activated protein kinase cascade and proliferation of rat renal mesangial cells. Br J Pharmacol (1994) 1.10
Upregulation of group IB secreted phospholipase A(2) and its M-type receptor in rat ANTI-THY-1 glomerulonephritis. Kidney Int (2006) 1.10
Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis. Clin Cancer Res (1999) 1.10
Activation of protein kinase C subtypes alpha, gamma, delta, epsilon, zeta, and eta by tumor-promoting and nontumor-promoting agents. Biochem Pharmacol (1997) 1.09
Platelet-derived growth factor and angiotensin II stimulate the mitogen-activated protein kinase cascade in renal mesangial cells: comparison of hypertrophic and hyperplastic agonists. Biochem J (1995) 1.09
Decorin deficiency in diabetic mice: aggravation of nephropathy due to overexpression of profibrotic factors, enhanced apoptosis and mononuclear cell infiltration. J Physiol Pharmacol (2009) 1.08
A lymphoma plasma membrane-associated protein with ankyrin-like properties. J Cell Biol (1986) 1.08
A case of testicular lupus. Lupus (2000) 1.07
Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). Osteoporos Int (2012) 1.07
What do patients and their carers want to know about stroke? A two-year follow-up study. Clin Rehabil (1998) 1.07
Tumour promotor 12-O-tetradecanoylphorbol 13-acetate inhibits angiotensin II-induced inositol phosphate production and cytosolic Ca2+ rise in rat renal mesangial cells. FEBS Lett (1986) 1.07
Inducible NO synthase: role in cellular signalling. J Exp Biol (1999) 1.06
Momentum and energy dependence of the anomalous high-energy dispersion in the electronic structure of high temperature superconductors. Phys Rev Lett (2007) 1.06
Periprosthetic metastatic carcinoma. Pitfalls in the management of two cases initially diagnosed as osteolysis. J Arthroplasty (1996) 1.06
Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase. Br J Cancer (2012) 1.06
Anti-inflammatory effects of sevoflurane and mild hypothermia in endotoxemic rats. Acta Anaesthesiol Scand (2007) 1.06
Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie (2010) 1.06
Interferon-gamma mediates gene expression of IL-18 binding protein in nonleukocytic cells. Biochem Biophys Res Commun (2000) 1.06
Selective inhibition of cyclooxygenase 2. Biochem Pharmacol (1994) 1.06
Ceramide binds to the CaLB domain of cytosolic phospholipase A2 and facilitates its membrane docking and arachidonic acid release. FASEB J (2000) 1.05
Problems in the early recognition of congenital hip dislocation. Br Med J (1971) 1.04
Role of protein kinase C in inhibition of renin release caused by vasoconstrictors. Am J Physiol (1986) 1.04
Active transport of an antibiotic rifamycin derivative by the outer-membrane protein FhuA. Structure (2001) 1.04
Serum antibodies in human pancreatic disease. Gut (1975) 1.04
Transport and communication systems in health services. Trop Doct (1977) 1.03
Localization of type X collagen in canine growth plate and adult canine articular cartilage. J Orthop Res (1991) 1.03
Selective ceramide binding to protein kinase C-alpha and -delta isoenzymes in renal mesangial cells. Biochemistry (1998) 1.02
Dermatomyositis associated with multifocal lipoatrophy. J Am Acad Dermatol (1990) 1.01
Interleukin-1beta induces chronic activation and de novo synthesis of neutral ceramidase in renal mesangial cells. J Biol Chem (2001) 1.01
The early management of varus feet in myelomeningocele. J Bone Joint Surg Br (1971) 1.01
Nitric oxide donors induce stress signaling via ceramide formation in rat renal mesangial cells. J Biol Chem (1999) 1.01
Molecular and electronic structure in NaCl electrolytes of varying concentration: identification of spectral fingerprints. J Chem Phys (2006) 1.00
Interleukin-1 beta- and forskolin-induced synthesis and secretion of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by transforming growth factor-beta 2. J Biol Chem (1992) 1.00
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int (2013) 1.00
Effect of extracellular ATP on contraction, cytosolic calcium activity, membrane voltage and ion currents of rat mesangial cells in primary culture. Br J Pharmacol (1993) 1.00